The Marlborough, MA-based company said it will have a limited launch of the Watchman FLX Left Atrial Appendage Closure (LAAC) technology and a broader launch in 4Q20.
- Pain Points When Maintaining a Cleanroom
- Manufacturing Durable Diabetes Tech for the 21st Century
- Innovation in Patient Monitoring and Wearables
- More Layoffs Signal COVID-19 Testing Boom Is Over
- Increasing COVID Numbers in China Creates Uncertainty
- High-Quality (Level 4) PMCF Surveys: What Are They?